definiens: shall mean approval of the JDC, JCC or JSC ( or, if applicable, theExecutive Officers pursuant to Section 13.1 or the Expert pursuant to Section 13.3 ) of ( a ) a GDP providing for the conduct ofClinical Studies, GLP tox studies or other studies intended to support an IND filing, with respect to any Licensed Compoundother than the Existing Compound, or any Product other than the Existing Product, including a Product consisting of a differentformulation of the Initial Compound, ( b ) the Manufacture of any Licensed Compound other than the Existing Compound, or anyProduct other than the Existing Product, for activities described in the foregoing clause ( a ), or ( c ) the Commercialization ( orManufacture for Commercialization ) of any Licensed Compound other than the Existing Compound, or any Product other thanthe Existing Product